title: Genetic engineering of the donor as an approach to clinical xenotransplantation.
authors.affiliation: Imutran Ltd (A Novartis Pharma AG Company), Cambridge, United Kingdom.
authors.forename: E
authors.initials: E
authors.lastname: Cozzi
authors.forename: B
authors.initials: B
authors.lastname: Soin
authors.forename: B
authors.initials: B
authors.lastname: Holmes
authors.forename: D
authors.initials: D
authors.lastname: White
mesh_terms: D000818:Animals; D030801:Animals, Genetically Modified; D000910:Antibodies, Heterophile / Q000276:immunology; D015478:Antigens, Heterophile / Q000276:immunology; D005818:Genetic Engineering / Q000379:methods*; D006084:Graft Rejection / Q000517:prevention & control; D006801:Humans; D009844:Oligosaccharides / Q000276:immunology; D011323:Primates; D013552:Swine; D014183:Transplantation, Heterologous / Q000276:immunology / Q000379:methods*
chemical_list: D000910:Antibodies, Heterophile; D015478:Antigens, Heterophile; D009844:Oligosaccharides